secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001213900-22-044758
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q2 revenue up 124% to $12.1M; diluted EPS $0.21 vs $(0.02) YoY
--------------------------------------------------------------------------------

- Revenue $12.1M, up 124% from $5.4M in Q2 2021; net income $3.5M vs net loss $(0.3M).
- Diluted EPS $0.21 vs $(0.02); adjusted EBITDA $4.7M vs $(0.1M).
- Gross margin improved to 68.6% from 61.1%; cash and equivalents $33.7M.
- Received orders for 10 TransDermal Infusion Systems from Hair Enhancement Centers.
- Affirms expectations for continued Q3 growth and full-year profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390022044758/0001213900-22-044758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390022044758/ea163775-8k_sensus.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-044758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer